Open access
105
Views
50
CrossRef citations to date
0
Altmetric
Original Research
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
Nanshan Zhong1 State Key Laboratory of Respiratory Diseases, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence[email protected]
, Changzheng Wang2 Institute of Respiratory Disease, Xin Qiao Hospital, Third Military Medical University, Chongqing City, Chongqing, People’s Republic of China
, Xiangdong Zhou3 Department of Respiratory Medicine, Southwest Hospital, Third Military Medical University, Chongqing City, Chongqing, People’s Republic of China
, Nuofu Zhang1 State Key Laboratory of Respiratory Diseases, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China
, Michael Humphries4 Beijing Novartis Pharma Co. Ltd., Shanghai, People’s Republic of China
, Linda Wang4 Beijing Novartis Pharma Co. Ltd., Shanghai, People’s Republic of China
, Chau Thach5 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
, Francesco Patalano6 Novartis Pharma AG, Basel, Switzerland
& Donald Banerji5 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
show all
Pages 1015-1026
|
Published online: 05 Jun 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.